UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-16209 ARCH CAPITAL GROUP LTD. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identifi ...

Exhibit 99.1 Global Medical REIT Announces Second Quarter 2025 Financial Results – Appoints Mark Decker, Jr. as Chief Executive Officer – – Completes Acquisition of Previously Announced $69.6 Million Five-Property Medical Portfolio – – Reaffirms Full Year 2025 AFFO Guidance – Bethesda, MD – August 5, 2025 – (BUSINESS WIRE) – Global Medical REIT Inc. (NYSE: GMRE) (the "Company" or "GMRE"), today announced financial results for the three and six months ended June 30, 2025 and other data. Mark Decker, Jr., Chi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 1-8951 M.D.C. HOLDINGS, INC. (Exact name of Registrant as specified in its charter) (State or other jurisd ...

| | | | Three Months Ended | | | | | --- | --- | --- | --- | --- | --- | --- | | | | | | | March 31, | | | (in millions, except per share amounts) | June 30, 2025 | | June 30, 2024 | | 2025 | | | Total Revenue | $ | 849 | $ | 693 $ | | 874 | | Contract Drilling Services Revenue | | 812 | | 661 | | 832 | | Net Income (Loss) | | 43 | | 195 | | 108 | | Adjusted EBITDA* | | 282 | | 271 | | 338 | | Adjusted Net Income (Loss)* | | 20 | | 105 | | 42 | | Basic Earnings (Loss) Per Share | | 0.27 | | 1.37 | | 0.68 | ...

RYAM Reports Second Quarter 2025 Results Long-Term Strategic Direction and Value Creation Remain Firmly Intact JACKSONVILLE, Fla., August 5, 2025 - Rayonier Advanced Materials Inc. (NYSE:RYAM) (the "Company") today reported results for its second quarter ended June 28, 2025. "Our second quarter results were impacted by a series of extraordinary and largely non-recurring challenges, including tariff volatility, operational disruptions and significant non-cash charges," said De Lyle Bloomquist, President and ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 WASHINGTON, D.C. 20549 For the transition period from ___ to ___ FORM 10-Q Commission File Number: 001-42364 CeriBell, Inc. (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 (Exact Name of Registrant as Specified in its Charter) | Delaware | 47-1785452 | ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 micromobility.com, Inc. (Exact Name of Registrant as Specified in Its Charter) FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39136 (State or other jurisdiction of incorporation or organi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Or For the transition period from to Commission File Number: 1-12139 SEALED AIR CORPORATION (Exact name of registrant as specified in its charter) | Delaware | 65-0654331 | | --- | --- | | (Sta ...

[Financial Highlights and Executive Summary](index=1&type=section&id=StoneX%20Group%20Inc.%20Reports%20Fiscal%202025%20Third%20Quarter%20Financial%20Results) [Q3 FY2025 Financial Highlights](index=1&type=section&id=Q3%20FY2025%20Financial%20Highlights) StoneX Group reported a **4%** year-over-year increase in quarterly **net operating revenues** to **$488.3 million** and a **2%** rise in **net income** to **$63.4 million** for the third quarter of fiscal 2025. **Diluted EPS** was **$1.22**, a slight decrease from the prior year, partly due to **$8.9 million** in **acquisition-related charges** Q3 FY2025 Key Financial Metrics | Metric | Q3 FY2025 | Change vs. Q3 FY2024 | | :--- | :--- | :--- | | Net Operating Revenues | $488.3 million | +4% | | Net Income | $63.4 million | +2% | | Diluted EPS | $1.22 | -2% | | Return on Equity (ROE) | 13.1% | -2.6 p.p. | - The quarter's results were impacted by **$8.9 million** in **acquisition-related charges**, which reduced **diluted EPS** by approximately **$0.12**. These charges included **$6.5 million** in **bridge loan financing fees** and **$2.4 million** in **professional fees**[2](index=2&type=chunk) [Executive Commentary and Strategic Developments](index=1&type=section&id=Executive%20Commentary%20and%20Strategic%20Developments) The Executive Vice-Chairman highlighted the company's diversified business model, where strong growth in the Institutional and Self-Directed/Retail segments offset declines in the Commercial segment caused by lower commodity volatility. The company successfully closed the acquisitions of R.J. O'Brien and The Benchmark Company, LLC post-quarter end, which is expected to significantly enhance its global derivatives and capital markets offerings - The company's diversified business model showed resilience, with strong performance in the **Institutional** (notably equities) and **Self-Directed/Retail** segments compensating for weakness in **Commercial** businesses[2](index=2&type=chunk) - On July 31, 2025, the company closed the acquisitions of **R.J. O'Brien** and **The Benchmark Company, LLC**[3](index=3&type=chunk) - **R.J. O'Brien** is positioned to make **StoneX** a **market leader** in global derivatives, having generated approximately **$766 million** in **revenue** and **$170 million** in **EBITDA** in calendar 2024[3](index=3&type=chunk) - **The Benchmark Company, LLC** acquisition enhances the **capital markets offering** with a full-service investment banking firm, expanding the client base and capabilities[3](index=3&type=chunk) [Consolidated Financial Performance](index=2&type=section&id=Consolidated%20Financial%20Performance) [Consolidated Financial Statements Summary](index=2&type=section&id=StoneX%20Group%20Inc.%20Summary%20Financials) For the third quarter of FY2025, total revenues grew **29%** YoY to **$34.8 billion**, driven by a significant increase in sales of physical commodities. **Net operating revenues** rose **4%** to **$488.3 million**. **Net income** increased by **2%** to **$63.4 million**, while **diluted EPS** decreased slightly by **2%** to **$1.22**. For the nine months ended June 30, 2025, **net income** grew **20%** to **$220.2 million** Consolidated Financial Results (in millions, except per share data) | Metric | Three Months Ended June 30, 2025 | Three Months Ended June 30, 2024 | % Change | | :--- | :--- | :--- | :--- | | Total Revenues | $34,828.8 | $27,069.7 | 29% | | Net Operating Revenues | $488.3 | $468.5 | 4% | | Income Before Tax | $85.6 | $88.0 | (3)% | | Net Income | $63.4 | $61.9 | 2% | | Diluted EPS | $1.22 | $1.25 | (2)% | | Metric | Nine Months Ended June 30, 2025 | Nine Months Ended June 30, 2024 | % Change | | :--- | :--- | :--- | :--- | | Total Revenues | $99,654.8 | $68,748.8 | 45% | | Net Operating Revenues | $1,467.7 | $1,312.4 | 12% | | Income Before Tax | $299.6 | $256.0 | 17% | | Net Income | $220.2 | $184.1 | 20% | | Diluted EPS | $4.32 | $3.76 | 15% | [Net Operating Revenues Analysis](index=4&type=section&id=Net%20Operating%20Revenues) Consolidated **net operating revenues** increased **4%** YoY to **$488.3 million** in Q3. This growth was primarily driven by a **46%** surge in **Securities** revenues. However, this was partially offset by significant declines in **Physical Contracts** (**-40%**), **Listed Derivatives** (**-13%**), and **OTC Derivatives** (**-11%**), reflecting reduced commodity market volatility Net Operating Revenues by Product (in millions) | Product | Q3 2025 | Q3 2024 | % Change | | :--- | :--- | :--- | :--- | | Securities | $125.5 | $86.2 | 46% | | FX/CFD contracts | $77.4 | $67.6 | 14% | | Physical contracts | $33.3 | $55.8 | (40)% | | Listed derivatives | $56.9 | $65.3 | (13)% | | OTC derivatives | $58.8 | $66.2 | (11)% | | Interest, net / fees | $73.9 | $86.4 | (14)% | | **Total** | **$488.3** | **$468.5** | **4%** | [Interest Expense Analysis](index=4&type=section&id=Interest%20expense) Total interest expense for Q3 FY2025 rose **22%** YoY to **$391.4 million**. The increase was mainly due to a **25%** rise in interest expense from trading activities, particularly in fixed income securities and securities borrowing, reflecting growth in those businesses. Corporate funding interest expense included a one-time **$6.5 million** fee for bridge loan financing related to the R.J. O'Brien acquisition - Interest expense from trading activities increased **25%** YoY to **$371.3 million**, driven by growth in the **security repo** and **securities lending businesses**[14](index=14&type=chunk) - Corporate funding interest expense for the quarter included **$6.5 million** in **bridge loan financing fees** related to the **R.J. O'Brien** acquisition[15](index=15&type=chunk) [Expense Structure (Variable vs. Fixed)](index=5&type=section&id=Variable%20vs.%20Fixed%20Expenses) The company's expense structure remained consistent year-over-year. In Q3 FY2025, **total non-interest expenses** were **$546.0 million**, with **variable expenses** comprising **53%** and **non-variable expenses** making up **47%**. This is a similar split to the prior-year quarter Expense Structure Breakdown - Q3 2025 vs Q3 2024 (in millions) | Expense Type | Q3 2025 | % of Total | Q3 2024 | % of Total | | :--- | :--- | :--- | :--- | :--- | | Total variable expenses | $288.5 | 53% | $264.7 | 52% | | Total non-variable expenses | $257.5 | 47% | $241.7 | 48% | | **Total non-interest expenses** | **$546.0** | **100%** | **$506.4** | **100%** | [Balance Sheet Summary](index=11&type=section&id=Balance%20Sheet%20Summary) As of June 30, 2025, **StoneX** reported **total stockholders' equity** of **$1.98 billion**, an increase from **$1.71 billion** at the end of fiscal year 2024. Key assets such as 'Securities purchased under agreements to resell' and 'Financial instruments owned' saw significant increases. **Net asset value per share** grew to **$40.36** from **$35.75** over the same period Key Balance Sheet Items (in millions) | Item | June 30, 2025 | September 30, 2024 | | :--- | :--- | :--- | | Cash and cash equivalents | $1,313.1 | $1,269.0 | | Securities purchased under agreements to resell | $8,159.3 | $5,201.5 | | Financial instruments owned, at fair value | $8,973.9 | $6,767.1 | | Securities sold under agreements to repurchase | $13,375.4 | $8,581.3 | | Stockholders' equity | $1,978.8 | $1,709.1 | - **Net asset value per share** increased to **$40.36** as of June 30, 2025, compared to **$35.75** as of September 30, 2024[33](index=33&type=chunk) [Segment Performance Analysis](index=5&type=section&id=Segment%20Results) [Commercial Segment](index=6&type=section&id=Commercial) The **Commercial** segment experienced a significant downturn in Q3, with **segment income** falling **36%** YoY to **$80.2 million**. This was driven by a **24%** decrease in **net operating revenues** to **$168.3 million**, primarily due to lower performance in physical contracts (**-44%**) and derivatives, reflecting diminished commodity market volatility Commercial Segment Performance (in millions) | Metric | Q3 2025 | Q3 2024 | % Change | | :--- | :--- | :--- | :--- | | Operating Revenues | $225.8 | $262.2 | (14)% | | Net Operating Revenues | $168.3 | $220.5 | (24)% | | Segment Income | $80.2 | $125.7 | (36)% | - **Net operating revenues** from **Physical contracts** fell **44%** YoY, and **Listed Derivatives** fell **18%** YoY, contributing to the segment's decline[24](index=24&type=chunk) [Institutional Segment](index=7&type=section&id=Institutional) The **Institutional** segment delivered strong results, with **segment income** increasing **41%** YoY to **$87.4 million**. This growth was fueled by a **27%** rise in **net operating revenues** to **$200.1 million**. The standout performer was **Securities**, where **net operating revenues** surged **48%** YoY, driven by a **25%** increase in **average daily volume** and a **15%** rise in **rate per million** Institutional Segment Performance (in millions) | Metric | Q3 2025 | Q3 2024 | % Change | | :--- | :--- | :--- | :--- | | Operating Revenues | $626.0 | $508.9 | 23% | | Net Operating Revenues | $200.1 | $157.7 | 27% | | Segment Income | $87.4 | $62.2 | 41% | - **Securities net operating revenues** grew **48%** YoY to **$119.8 million**, supported by a **25%** increase in **average daily volume**[25](index=25&type=chunk)[27](index=27&type=chunk) [Self-Directed/Retail Segment](index=8&type=section&id=Self-Directed/Retail) The **Self-Directed/Retail** segment showed robust growth, with **segment income** jumping **49%** YoY to **$41.2 million**. **Net operating revenues** increased **18%** to **$80.6 million**, primarily driven by a **17%** rise in **net operating revenues** from **FX/CFD contracts**, which benefited from a **34%** increase in **average daily volume** Self-Directed/Retail Segment Performance (in millions) | Metric | Q3 2025 | Q3 2024 | % Change | | :--- | :--- | :--- | :--- | | Operating Revenues | $114.2 | $96.2 | 19% | | Net Operating Revenues | $80.6 | $68.5 | 18% | | Segment Income | $41.2 | $27.6 | 49% | - **FX/CFD contracts net operating revenues** grew **17%** to **$70.2 million**, as **average daily volume** increased **34%** YoY[28](index=28&type=chunk) [Payments Segment](index=9&type=section&id=Payments) The **Payments** segment delivered a stable performance in Q3, with **segment income** remaining flat YoY at **$28.1 million**. **Net operating revenues** saw a modest **3%** increase to **$50.2 million**. While the **average daily volume** of payments increased by **16%**, the **rate per million (RPM)** decreased by **6%**, resulting in steady overall results Payments Segment Performance (in millions) | Metric | Q3 2025 | Q3 2024 | % Change | | :--- | :--- | :--- | :--- | | Operating Revenues | $53.3 | $51.1 | 4% | | Net Operating Revenues | $50.2 | $48.7 | 3% | | Segment Income | $28.1 | $28.2 | 0% | - **Payments average daily volume (ADV)** increased **16%** YoY, but this was offset by a **6%** decrease in **rate per million (RPM)**[29](index=29&type=chunk) [Overhead Costs and Expenses](index=10&type=section&id=Overhead%20Costs%20and%20Expenses) Total **overhead costs and expenses** increased by **9%** YoY to **$140.4 million** in Q3. The rise was primarily driven by a **7%** increase in **compensation and benefits** and a **12%** increase in **other expenses**. Notably, **professional fees** rose **38%** and **non-trading technology support costs** increased **19%**. After allocating **$43.0 million** to operating segments, net overhead costs were **$97.4 million** Overhead Costs Breakdown (in millions) | Expense Category | Q3 2025 | Q3 2024 | % Change | | :--- | :--- | :--- | :--- | | Compensation and benefits | $78.6 | $73.6 | 7% | | Other expenses | $61.8 | $55.2 | 12% | | **Total Overhead Costs** | **$140.4** | **$128.8** | **9%** | - Significant drivers of the increase in 'Other expenses' were **Professional fees** (**+38%**) and **Non-trading technology and support** (**+19%**)[31](index=31&type=chunk) [Other Information](index=12&type=section&id=Other%20Information) [Conference Call & Web Cast](index=12&type=section&id=Conference%20Call%20%26%20Web%20Cast) The company will host a conference call and webcast on Wednesday, August 6, 2025, at **9:00 a.m. Eastern time** to discuss the financial results. A live webcast and replay will be available on the company's corporate website - A conference call to discuss financial results is scheduled for August 6, 2025, at **9:00 a.m. Eastern time**[34](index=34&type=chunk) [About StoneX Group Inc.](index=12&type=section&id=About%20StoneX%20Group%20Inc.) **StoneX Group Inc.** is a **Fortune-500 company** financial services company headquartered in New York City. It operates a global network connecting clients to the market ecosystem through digital platforms and expert services. With over **4,700 employees** in more than 80 offices, the company serves over **54,000 commercial, institutional, and payments clients**, and over **400,000 retail accounts** worldwide - **StoneX** is a **Fortune-500 company** with over **4,700 employees** serving more than **54,000 commercial, institutional, and payments clients**, and over **400,000 retail accounts** globally[36](index=36&type=chunk) [Forward-Looking Statements](index=12&type=section&id=Forward%20Looking%20Statements) This press release contains forward-looking statements regarding the company's financial condition, business strategy, and the anticipated impact of its recent acquisitions. These statements are based on current expectations and are subject to known and unknown risks and uncertainties, including market conditions, competition, and regulatory changes. The company claims safe harbor protection for these statements under the Private Securities Litigation Reform Act of 1995 - The report includes forward-looking statements concerning financial condition, business strategy, and the impact of acquisitions like **R.J. O'Brien**[37](index=37&type=chunk) - These statements involve risks and uncertainties, and the company cautions readers not to place undue reliance on them, claiming protection under the safe harbor provisions of the **Private Securities Litigation Reform Act of 1995**[38](index=38&type=chunk)[39](index=39&type=chunk)

Exhibit 99.1 Personalis Reports Second Quarter 2025 Financial Results Strong Q2 Clinical Momentum with 59% Sequential Growth in Test Volume FREMONT, Calif. – August 5, 2025 – Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the second quarter ended June 30, 2025, and recent accomplishments of its "Win-in-MRD" strategy: Second Quarter 2025 and Recent Business Highlights "The results of our "Win-in-MRD" strategy are clear, with an impr ...